bf/NASDAQ:APYX_icon.jpeg

COM:APYXMEDICAL

Apyx Medical

  • Stock

USD

Last Close

1.42

22/11 21:00

Market Cap

46.08M

Beta: -

Volume Today

41.43K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
8.20M
-
7.07M
13.76%
5.84M
17.38%
6.06M
3.69%
6.34M
4.70%
5.87M
7.46%
5.13M
12.57%
4.55M
11.31%
5.41M
18.99%
9.29M
71.53%
10.86M
16.93%
average payables
931.50K
-
1.31M
40.26%
1.38M
5.89%
1.41M
1.92%
1.59M
13.09%
1.50M
5.74%
1.90M
26.15%
1.94M
2.32%
2.07M
6.75%
2.65M
27.96%
2.69M
1.53%
average receivables
2.43M
-
1.99M
18.13%
2.46M
23.48%
3.83M
55.75%
4.79M
25.23%
4.94M
2.94%
7.12M
44.20%
13.27M
86.50%
19.25M
44.99%
19.70M
2.38%
16.15M
18.04%
book value per share
1.21
-
0.26
78.10%
0.96
263.83%
0.96
0.62%
0.70
26.64%
2.64
277.18%
2.09
20.92%
1.86
10.95%
1.56
16.01%
1.09
30.39%
0.77
29.17%
capex per share
-0.03
-
-0.04
6.62%
-0.02
51.24%
-0.01
39.74%
-0.02
90.50%
-0.01
44.92%
-0.04
249.10%
-0.02
55.53%
-0.02
24.01%
-0.03
38.95%
-0.02
47.39%
capex to depreciation
-0.71
-
-0.72
1.15%
-0.52
27.91%
-0.39
24.85%
-0.90
130.09%
-0.54
39.48%
-1.73
218.00%
-0.66
62.04%
-0.80
22.24%
-1.13
41.74%
-0.77
32.13%
capex to operating cash flow
0.23
-
1.51
551.59%
0.07
95.18%
0.10
38.55%
0.17
67.11%
0.02
89.74%
0.07
307.60%
0.04
48.65%
0.07
91.34%
0.05
28.02%
0.10
103.89%
capex to revenue
-0.02
-
-0.02
8.42%
-0.01
37.34%
-0.01
45.25%
-0.02
105.52%
-0.02
35.56%
-0.05
112.41%
-0.02
54.63%
-0.01
28.92%
-0.02
52.27%
-0.01
55.13%
cash per share
0.45
-
0.32
28.00%
0.49
50.26%
0.53
8.62%
0.32
39.91%
2.35
643.67%
1.73
26.69%
1.23
29.03%
0.90
26.61%
0.30
67.16%
1.26
326.99%
days of inventory on hand
212.38
-
111.85
47.34%
128.18
14.60%
120.12
6.29%
124.57
3.70%
322.82
159.15%
204.19
36.75%
144.86
29.06%
165.86
14.49%
279.99
68.81%
94.75
66.16%
days payables outstanding
26.75
-
30.33
13.37%
26.12
13.87%
31.33
19.92%
30.22
3.55%
88.14
191.69%
95.79
8.68%
54.03
43.59%
64.38
19.15%
63.35
1.61%
25.89
59.12%
days sales outstanding
30.70
-
26.27
14.44%
36.17
37.69%
47.17
30.41%
45.59
3.33%
109.70
140.61%
119.53
8.96%
228.24
90.94%
159.21
30.24%
149.62
6.02%
97.98
34.51%
debt to assets
0.10
-
0.14
39.95%
0.11
23.33%
0.09
16.92%
0.09
4.49%
0.00
98.40%
0.01
813.79%
0.01
31.83%
0.00
51.34%
0.02
246.40%
0.42
2,654.11%
debt to equity
0.15
-
0.73
376.04%
0.14
80.53%
0.12
17.22%
0.13
9.77%
0.00
98.76%
0.02
896.78%
0.01
33.28%
0.01
46.47%
0.02
272.94%
1.26
5,832.77%
dividend yield
earnings yield
-0.04
-
-0.15
296.37%
-0.03
77.33%
-0.02
34.76%
-0.02
11.89%
0.30
1,297.25%
-0.07
122.87%
-0.05
29.10%
-0.03
28.55%
-0.29
734.55%
-0.21
28.42%
enterprise value
109.66M
-
112.56M
2.65%
148.94M
32.32%
166.11M
11.53%
196.17M
18.10%
198.38M
1.13%
230.54M
16.21%
205.09M
11.04%
409.57M
99.71%
71.37M
82.57%
85.56M
19.88%
enterprise value over ebitda
-45.58
-
-19.24
57.78%
-21.32
10.79%
-43.80
105.46%
-52.44
19.71%
-15.19
71.04%
-11.58
23.73%
-10.59
8.57%
-27.66
161.10%
-3.12
88.73%
-4.44
42.52%
ev to operating cash flow
-43.24
-
-269.93
524.25%
-25.74
90.46%
-58.55
127.45%
-52.96
9.54%
-9.44
82.17%
-12.48
32.17%
-12.77
2.30%
-39.20
207.06%
-3.52
91.02%
-16.30
363.16%
ev to sales
4.63
-
4.07
12.26%
5.05
24.08%
4.54
10.11%
5.05
11.25%
11.89
135.65%
8.19
31.12%
7.40
9.62%
8.44
14.06%
1.60
81.01%
1.63
1.93%
free cash flow per share
-0.18
-
-0.06
66.65%
-0.26
332.60%
-0.11
55.37%
-0.14
21.00%
-0.64
367.59%
-0.58
9.88%
-0.49
16.17%
-0.33
33.12%
-0.62
89.55%
-0.17
72.92%
free cash flow yield
-0.03
-
-0.01
66.65%
-0.04
332.60%
-0.02
55.37%
-0.02
21.00%
-0.10
367.59%
-0.07
31.08%
-0.07
1.50%
-0.03
62.44%
-0.26
938.47%
-0.06
75.82%
graham net net
0.10
-
-0.57
662.42%
0.37
164.87%
0.44
21.11%
0.25
43.46%
2.31
819.02%
1.61
30.33%
1.36
15.22%
1.03
24.40%
0.46
55.65%
0.20
56.85%
graham number
2.58
-
2.41
6.83%
2.19
9.17%
1.76
19.48%
1.59
9.40%
10.71
571.99%
5.21
51.37%
3.82
26.70%
3.95
3.37%
4.06
2.97%
3.06
24.66%
income quality
0.58
-
0.02
95.87%
1.08
4,365.42%
0.72
33.34%
0.73
1.88%
-0.33
144.86%
0.94
385.61%
1.35
43.93%
0.69
49.06%
0.87
26.73%
0.28
67.80%
intangibles to total assets
0.06
-
0.08
24.37%
0.06
17.90%
0.05
15.22%
0.06
11.17%
0.00
96.70%
0
100%
0
0
0
0
interest coverage
-15.47
-
-38.74
150.42%
-44.22
14.15%
-24
45.72%
-38.71
61.31%
26.56
168.61%
-2.61K
9,940.94%
-436.59
83.30%
-1.44K
230.93%
-1.57K
8.72%
-8.05
99.49%
interest debt per share
0.20
-
0.20
1.48%
0.14
28.91%
0.12
17.43%
0.09
19.74%
-0.01
111.86%
0.03
398.76%
0.02
36.99%
0.01
56.52%
0.02
156.09%
1.04
4,329.06%
inventory turnover
1.72
-
3.26
89.88%
2.85
12.74%
3.04
6.71%
2.93
3.57%
1.13
61.41%
1.79
58.10%
2.52
40.96%
2.20
12.66%
1.30
40.76%
3.85
195.51%
invested capital
0.15
-
0.73
376.04%
0.14
80.53%
0.12
17.22%
0.13
9.77%
0.00
98.76%
0.02
896.78%
0.01
33.28%
0.01
46.47%
0.02
272.94%
1.26
5,832.77%
market cap
114.32M
-
114.88M
0.49%
157.43M
37.04%
177.49M
12.74%
203.29M
14.53%
214.71M
5.62%
288.22M
34.24%
246.33M
14.54%
440.14M
78.68%
80.77M
81.65%
90.71M
12.31%
net current asset value
7.98M
-
-4.77M
159.85%
14.00M
393.21%
17.65M
26.10%
13.59M
23.01%
81.67M
500.95%
63.25M
22.56%
55.84M
11.72%
46.02M
17.57%
28.99M
37.01%
18.04M
37.76%
net debt to ebitda
1.94
-
0.40
79.54%
1.22
206.33%
3.00
146.95%
1.90
36.64%
1.25
34.28%
2.90
131.87%
2.13
26.51%
2.06
3.10%
0.41
80.12%
0.27
34.83%
net income per share
-0.25
-
-0.97
296.37%
-0.22
77.33%
-0.14
34.76%
-0.16
11.89%
1.93
1,297.25%
-0.58
129.90%
-0.35
39.66%
-0.44
27.22%
-0.67
52.33%
-0.54
19.86%
operating cash flow per share
-0.14
-
-0.02
83.64%
-0.24
912.49%
-0.10
56.51%
-0.12
13.99%
-0.63
437.08%
-0.54
14.35%
-0.47
13.40%
-0.30
35.19%
-0.59
93.05%
-0.15
74.20%
payables turnover
13.64
-
12.03
11.80%
13.97
16.11%
11.65
16.61%
12.08
3.68%
4.14
65.72%
3.81
7.99%
6.76
77.28%
5.67
16.07%
5.76
1.64%
14.10
144.63%
receivables turnover
11.89
-
13.90
16.88%
10.09
27.37%
7.74
23.32%
8.01
3.45%
3.33
58.44%
3.05
8.22%
1.60
47.63%
2.29
43.36%
2.44
6.41%
3.73
52.70%
research and ddevelopement to revenue
0.05
-
0.05
3.94%
0.07
43.04%
0.07
2.31%
0.06
11.67%
0.15
134.36%
0.14
8.52%
0.14
4.50%
0.09
37.04%
0.10
14.63%
0.09
9.36%
return on tangible assets
-0.14
-
-0.75
440.95%
-0.18
75.83%
-0.12
34.80%
-0.17
46.14%
0.67
485.82%
-0.23
134.59%
-0.16
30.77%
-0.22
37.68%
-0.45
103.27%
-0.24
47.47%
revenue per share
1.34
-
1.56
16.43%
1.21
22.18%
1.34
10.05%
1.24
7.31%
0.50
59.37%
0.83
64.35%
0.81
1.98%
1.41
74.47%
1.29
8.75%
1.51
17.25%
roe
-0.20
-
-3.68
1,709.89%
-0.23
93.77%
-0.15
34.35%
-0.23
52.53%
0.73
417.42%
-0.28
137.81%
-0.19
32.24%
-0.28
51.48%
-0.62
118.84%
-0.70
13.15%
roic
-0.11
-
-0.94
763.56%
-0.26
72.01%
-0.13
49.92%
-0.21
56.12%
-0.11
46.12%
-0.28
154.11%
-0.19
32.69%
-0.27
44.11%
-0.61
123.99%
-0.27
55.65%
sales general and administrative to revenue
0.42
-
0.48
15.16%
0.59
21.42%
0.52
11.49%
0.54
3.86%
1.27
134.53%
1.29
1.36%
1.21
5.58%
0.90
25.82%
1.08
20.02%
shareholders equity per share
1.21
-
0.26
78.10%
0.96
263.83%
0.96
0.62%
0.70
26.64%
2.64
277.18%
2.09
20.92%
1.86
10.95%
1.56
16.01%
1.09
30.39%
0.77
29.17%
stock based compensation to revenue
0.02
-
0.01
34.46%
0.02
38.96%
0.02
13.40%
0.02
1.42%
0.09
308.00%
0.13
39.17%
0.15
19.44%
0.10
30.97%
0.15
43.47%
0.10
35.07%
tangible asset value
19.25M
-
2.75M
85.69%
21.39M
676.83%
24.31M
13.69%
20.16M
17.09%
87.58M
334.45%
71.26M
18.63%
63.86M
10.38%
54.01M
15.42%
37.79M
30.02%
26.92M
28.76%
tangible book value per share
1.09
-
0.16
85.76%
0.88
466.86%
0.89
0.84%
0.64
27.61%
2.64
311.35%
2.09
20.74%
1.87
10.76%
1.57
15.72%
1.09
30.40%
0.78
28.98%
working capital
16.91M
-
11.60M
31.41%
17.92M
54.50%
21.27M
18.67%
16.57M
22.07%
81.81M
393.63%
64.42M
21.26%
56.94M
11.62%
47.53M
16.52%
31.12M
34.52%
57.62M
85.15%

All numbers in USD (except ratios and percentages)